chapter 3 present new
TRANSCRIPT
-
8/21/2019 Chapter 3 Present NEW
1/55
PRESENTER:
MARINA YUSOFF 2010672752
NUR SYAFIQAH KAMARUDIN 2010847576
CAROLINE APAU 2010488388
AZWADI ALI 2009424756
NURUL AFIQAH MOHD ZAKI 2010802956
PRODUCTION OF
1 KG PER YEAR
INSULIN
-
8/21/2019 Chapter 3 Present NEW
2/55
PROCESS BACKGROUND/SELECTION
CHAPTER 1
http://c/Users/User/Desktop/presentation-dp/Prezi.exehttp://c/Users/User/Desktop/presentation-dp/Prezi.exe -
8/21/2019 Chapter 3 Present NEW
3/55
INTRODUCTION
Diabetes is one of the chronic diseases
occurs when the glucose level in blood is
increases due to breakdown ofcarbohydrates
Insulin can help to convert excessive
glucose into glycogen to be stored in liver
-
8/21/2019 Chapter 3 Present NEW
4/55
Human insulin can be produced by
four different methods
Extraction from human pancreas
Chemical synthesis via individual amino
acids. Conversion of pork insulin of
semisynthesis.
Fermentation of genetically engineeredmicroorganisms.
-
8/21/2019 Chapter 3 Present NEW
5/55
fermentation of genetically engineered
microorganisms or can be simply called as
recombinant DNA technology is chosen inthis project
This is because this technique is safe,
high recovery, high purity and almostsame with human insulin
-
8/21/2019 Chapter 3 Present NEW
6/55
Genetic Modification Organism
-
8/21/2019 Chapter 3 Present NEW
7/55
GENERAL PROCESS
Consists of fourth teen important steps
35 equipments and reactors involve in this
batch process Duration for each batch is 6 days
Production for each batch is 1.81 kg
Production per year is 100 kg
Downstream process to improve the
quality of desired product
-
8/21/2019 Chapter 3 Present NEW
8/55
Fermentation process
Cellisolation
CellDisruptio
n
Centrifugation
SolubilizeInclusionBodies
(IB)
CNBr-Cleavage
SulfitolysisRefolding
HICcolumn
Enzymatic
Conversion
ReversePhase
Chromatography
Secondstage
purification
PolishingFreeze
Dry
-
8/21/2019 Chapter 3 Present NEW
9/55
MARKET ANALYSISN
CHAPTER 2
-
8/21/2019 Chapter 3 Present NEW
10/55
Insulin Worldwide Market
Top 10 Coun tr ies Number of People with Diabetes
-
8/21/2019 Chapter 3 Present NEW
11/55
Insulin Worldwide Market
-
8/21/2019 Chapter 3 Present NEW
12/55
Trends in the Current DepressedMarket
The Price of Insul in
-
8/21/2019 Chapter 3 Present NEW
13/55
Profit Margin
-
8/21/2019 Chapter 3 Present NEW
14/55
Break Even Analysis
-
8/21/2019 Chapter 3 Present NEW
15/55
-
8/21/2019 Chapter 3 Present NEW
16/55
Break Even Calculation
Variab le Cos t
Cost Item
Formula value
Raw Material RM 286 millions
Waste Treatment RM 27 thousands
Utilities RM 382 thousands
Operating Labour RM 993 thousands
Maintenance and repairs
0.06FCI
RM 13 millions
Operating Supplies 0.009FCI RM 1.94 millions
Total
RM 302 millions
-
8/21/2019 Chapter 3 Present NEW
17/55
Break Even Calculation
Fixed Cos t
Cost Item Formula Value
Fixed capital investment FCI RM 215 millions
Local taxes and insurance 0.032FCI RM 6.88 millions
Plant overhead costs 0.708 + 0.036FCI RM 8.45 millions
Total
RM 230 millions
-
8/21/2019 Chapter 3 Present NEW
18/55
Break Even CalculationTotal Revenue
Total Revenue = Production of insulin x Price of
insulin
Production of insulin = 99.55 kg/year
Price of insulin = RM 11.4 millions
/year
=
-
8/21/2019 Chapter 3 Present NEW
19/55
Break Even CalculationBreak Even Po int (BEP)
BEP = (Fixed cost/ Contribution margin) x Production
Contribution Margin = Revenues Variable Cost
Contribution Margin = RM 834 millions
Fixed Cost = RM 230 millions
Production = 99.55 kg/year
BEP = 27.50 kg/year need to be
-
8/21/2019 Chapter 3 Present NEW
20/55
Cumulative Cash FlowOperat ing Cost for the First Year
Total Cost = Variable Cost + Fixed Cost
Variable Cost = RM 302 millions
Fixed Cost = RM 230 millions
Total Cost = RM 532 millions
-
8/21/2019 Chapter 3 Present NEW
21/55
Cumulative Cash FlowCumulative Cash Flow Analysis
Year
Total cost
Cumulative cash flow
1 - 532,678,960 - 532,678,960
2 - 372,514,550 - 905,193,510
3
1,136,861,000
231,667,490
4 1,136,861,000 1,368,528,490
5 1,136,861,000 2,505,389,940
6 1,136,861,000 3,642,250,490
7 1,136,861,000 4,779,111,490
8 1,136,861,000 5,915,972,490
9 1,136,861,000 7,052,833,490
10
1,136,861,000
8,189,694,490
-
8/21/2019 Chapter 3 Present NEW
22/55
Cumulative Cash FlowCumulat ive Cash Flow Diagram
-0.2
0
0.2
0.4
0.6
0.8
1
0 2 4 6 8 10 12CumulativeCashFlow
(1010)(RM)
Year
Payback Period
-
8/21/2019 Chapter 3 Present NEW
23/55
ConclusionMarket Analysis o n Insul in Produc t ion
Fixed Capital Investment is RM 215 millions and this cost isindependent of production rate.
The Total Production Cost is RM 532 millions. It is summation
of Variable Cost and Fixed Cost.
The total insulin sale per year is RM 11.4 millions.
Total Revenue = RM 1.14 billions.
Net annual Profit = RM 700 millions
Total Production = 99.55 kg/year
BEP = 27.50 kg/year Productions
Up the BEP, it has been estimated that the plant would gainsome profit and therefore this project can be considered as
profitable as the production rate also is in conjunction with the
supply and demand in Malaysia.
The payback period is estimated about 3 years
-
8/21/2019 Chapter 3 Present NEW
24/55
SITE SELECTION
CHAPTER 3
-
8/21/2019 Chapter 3 Present NEW
25/55
Chapter 3 : Site Selection
Comparison between Senai, Pulau Indah and Gebeng between several
criteria
A rating evaluation has been made
After all comparison, we decide to choose Gebeng Industrial Estate Phase
3
Gebeng Pulau Indah Senai
Total Rating 38 37 35
-
8/21/2019 Chapter 3 Present NEW
26/55
Location Description
a small town and main industrial area in Pahang state in Malaysia
near Kuantan Port
Kuantan is being identified as a Special Economic Zone (SEZ)
located inside East Coast Economic Region (ECER)
located only 5 kilometers from the Kuantan Port in Kuantan City
25km away from the Kuantan town and 250km from the Kuala
Lumpur
-
8/21/2019 Chapter 3 Present NEW
27/55
-
8/21/2019 Chapter 3 Present NEW
28/55
Land availability and prices
selling prices RM 15 per sq
can be bought with minimum 3 acres (130680 ft2) up to
maximum 250 acres (10890000 ft2)
So minimum price is RM 1,960,200 for 3 acres
-
8/21/2019 Chapter 3 Present NEW
29/55
Raw Material Availability
Supply within the Malaysia and imported from the
oversea
Company that responsible for been supplier within
Malaysia is Merck Sdn Bhd, Sigma-Aldrich (M) Sdn.Bhd, and Fisher CW Medical (M)
Raw materials will be transported from these company
via road
The other raw material imported from oversea istransported to nearest airport and port.
-
8/21/2019 Chapter 3 Present NEW
30/55
Transportation Network
Gebeng by-pass between Gebeng Industrial Estate andKuantan Port
The by-pass will directly link with the East CoastExpressway to connect Kuala Lumpur with Kuantan
Kuantan Port is located only 5 kilometers from theGebeng Industrial Estate
Sultan Ahmad Shah Airport, Kuantan is approximately35km from Gebeng Industrial Estate and connected via
Jalan Pintasan Kuantan Not compacted with other activities, so smooth trafficking
of the import and exporting process
-
8/21/2019 Chapter 3 Present NEW
31/55
Availability of Utilities
main electricity supplier in Gebeng Industrial Estate is
Tenaga Nasional Berhad (TNB)
Phase I and II is supported by its 132/11kV main intake,
for Phase III, two sources of electricity supply areavailable which are and 12/275kV main intake
water supply is Semambu Water Treatment Plant
capacity 2MG/D
main telecommunication supplier is Telekom Malaysiafor instance Integrated Systems Digital Network (ISDN),
digital line, MAYPAC, Internet and video conferencing
-
8/21/2019 Chapter 3 Present NEW
32/55
Availability of Labour
main labourssources is Kuantan population is
approximately 607,778 persons.
Also involves Kemaman area
Pahang provides access to skilled manpower as whichcan be acquired numerous institutions of further studies
Universities Others Facilities
University Teknology MARA
University Malaysia Pahang
International IslamicUniversity Malaysia
Kolej Islam Pahang,
Politeknik Sultan Haji Ahmad
ShahKolej Komuniti Kuantan Kolej
ShahPutra Kuantan
Kolej Poly-Tech MARA
Institut Kemajuan Ikhtisas
Pahang (IKIP) College
-
8/21/2019 Chapter 3 Present NEW
33/55
Government Incentives
Development of Gebeng Phase III which will beattraction for the investor to Pahang
The Eastern Industrial Corridor, which is the governmentbacked economic region developed into an ultra-modernindustrial region
Accelerated capital allowance provides a specialallowance, where the capital expenditure is written offwithin 3 years
water supply to 64 MG/D Building of new pipes and water tanks in Gebeng
Industrial Estate
-
8/21/2019 Chapter 3 Present NEW
34/55
MATERIAL BALANCE
CHAPTER 4
-
8/21/2019 Chapter 3 Present NEW
35/55
General Mass alance
Equation
-
8/21/2019 Chapter 3 Present NEW
36/55
1 batch approximately 6 days
100 kg/ yr X 1 yr/ 330 days X 6days/batch
= 1.818 kg/batch 330 days/ 1 yr X 6 days/ batch = 55
batches per year
Production rate = 100 kg/year
-
8/21/2019 Chapter 3 Present NEW
37/55
The calculation is based on the production rate of 100 kg/year of
insulin.
The target production rate per batch is 1.818 kg/batch.
Operating days for the plant is 330 days per year, 24 hours daily.
The system is a steady-state operation.
The system behaves as an ideal condition.
No leakage in the pipes or vessels inside the plant.
All the catalysts used during the process do not contribute to the
mass inside the system. The total input of substances to compressor, pump, valve, mixer or
heat exchanger is equal to the total output.
All calculations are done in kg/batch
-
8/21/2019 Chapter 3 Present NEW
38/55
TSB + O2+ N2+ NH3+ H2O + kanamycinbiomass
(E.coli)+ O2+ N2+ NH3+ H2O+CO2+ kanamycin + ATPs
-
8/21/2019 Chapter 3 Present NEW
39/55
Overall mass balance: total in = total output
The percentage of air consists of 21% of oxygen, 79% of
nitrogen
870 kg/batch of Ammonium gas is purge into this system Basis of 43 504 kg/batch air is purge into the fermenter
system
-
8/21/2019 Chapter 3 Present NEW
40/55
1.4% of oxygen from respiration of bacteria cell is
release as carbon dioxide
Conversion process for TSB is 95%
0.5 kg biomass can be generate for every 1 kg of TSBconsumed
kanamycin does not take part in the reaction so that total
input = total output
74 % of water will be increase after undergofermentation process due to biological process that
occurred.
-
8/21/2019 Chapter 3 Present NEW
41/55
-
8/21/2019 Chapter 3 Present NEW
42/55
Percentage error of calculation:
Manual calculation = 1.800kg/batch
Simulation = 1.810 kg/batch Target production = 1.814kg/batch
(1.810-1.800) /1.810 X 100% = 0.55 %
(1.814-1.800)/1.814X 100% = 0.77 %
-
8/21/2019 Chapter 3 Present NEW
43/55
ENERGY BALANCE
CHAPTER 5
-
8/21/2019 Chapter 3 Present NEW
44/55
Important in worldwide manufacturing plant to reduce the
cost and energy consumption.
To analyze and optimize the uses of energy in designinga plant.
-
8/21/2019 Chapter 3 Present NEW
45/55
The system is assume as an open system
Q-Ws= H+Ek+Ep
The equation reduced to
= =
=Hf+
= Hf+ [ ]
Ws, Ek and Ep =0
-
8/21/2019 Chapter 3 Present NEW
46/55
1. Assumptions:
Open system (Q=H) and steady state process
- No moving parts considered in the system
- All equipments are static
Heat from pressure change is neglected
All streams and reactions occur in liquid phase- Occurs in homogeneous mixture. Thus, solid and gas is not taken into
account.
Heat of mixing, Hm is neglected
2. Basis:
Tref = 25C = 298.15K Pref= 1atm Mass flowrate is in kg/hour
Heat capacity,Cp get from SUPERPRO library
Using heat of formation method due to the facts that heat of reaction method for certain standard conditions is
unknown.
-
8/21/2019 Chapter 3 Present NEW
47/55
-
8/21/2019 Chapter 3 Present NEW
48/55
ENVIRONMENTAL AND SAFETY CONSIDERATION
CHAPTER 6
-
8/21/2019 Chapter 3 Present NEW
49/55
Role of chemical engineer
Lack of consideration
Negative impact
-Human
-Animal
-Aquatic life
-
8/21/2019 Chapter 3 Present NEW
50/55
Follow the Malaysia Act & Regulation
-OSHA
-Environment Quality Act
(Air pollution, Scheduled Waste)
-Biosafety Act
Hazard
HIRARC
-
8/21/2019 Chapter 3 Present NEW
51/55
HAZARDOUS WASTE
-
8/21/2019 Chapter 3 Present NEW
52/55
-
8/21/2019 Chapter 3 Present NEW
53/55
Classification
-
8/21/2019 Chapter 3 Present NEW
54/55
Treatment
Biological Treatment
1.Inject with Chlorine
2.Sterilize the waste3.Send to the Jabatan Alam Sekitar
Chemical Treatment
Recycle
Send to the Jabatan Alam Sekitar
-
8/21/2019 Chapter 3 Present NEW
55/55
Management
Recycle
Waste area
Labeling the waste
Put the sign of hazardous area
Disposal to the sanitary landfill